Search clinical trials for: Fesoterodine PR

Total 253 results

Pfizer

Completed

Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.

Urinary Bladder, Neurogenic

Japan
Pfizer

Completed

A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition

Urinary Bladder, Neurogenic

France, United States, Spain, Korea, Republic of, United Kingdom, Malaysia, Taiwan, Finland, Japan, Lithuania, Italy, Turkey, Estonia, Slovakia, Belgium, Canada, Germany, Greece, India, Philippines, Poland, Russian Federation, South... and more
Pfizer

Completed

Study to Estimate the Relative Bioavailability Compared to Commercial Extended-release Tablet Formulation and the Effects of Food Or Sprinkling on Applesauce for Fesoterodine Sustained-release Beads-in-capsule Formulations in Healthy Adult Volunteers

Healthy

Belgium
Fondazione Salvatore Maugeri

Completed

Osteopathy in Chronic Obstructive Pulmonary Disease (COPD) Rehabilitation Trial

Chronic Obstructive Pulmonary Disease

Italy
University of Alberta
McGill University; Université de Sherbrooke; University of Toronto

Completed

The CaNadian Standardized Pulmonary Rehabilitation Efficacy Trial (CoNSPiRE)

Chronic Obstructive Pulmonary Disease (COPD)

Canada
University of Glasgow
NHS Research and Development

Completed

An Evaluation of Web Based Pulmonary Rehabilitation (webbasedPR)

Chronic Obstructive Pulmonary Disease

United Kingdom
Vedic Lifesciences Pvt. Ltd.

Completed

Cross-Over Study to Evaluate the Efficacy of E-PR-01 on Activity Induced Joint Pain

Joint Pain

India
Aveiro University
Fundação para a Ciência e a Tecnologia

Completed

Impact of Family-based Pulmonary Rehabilitation (PR) on Patients With Chronic Obstructive Pulmonary Disease (COPD) and Their Family Members

Chronic Obstructive Pulmonary Disease (COPD)

Portugal
Pfizer

Completed

BIOEQUIVALENCE STUDY IN HEALTHY PARTICIPANTS COMPARING 4 MG AND 8 MG FESOTERODINE EXTENDED-RELEASE TABLETS (TOVIAZ™), MANUFACTURED AT ZWICKAU VERSUS FREIBURG

Neurogenic Detrusor Overactivity

Belgium
Vedic Lifesciences Pvt. Ltd.

Completed

A Study to Evaluate the Efficacy of E-PR-01 on Musculoskeletal Health in Physically Active Individuals

Joint Pain

India
University Hospital, Brest

Recruiting

Impact on Quality of Life With Pulmonary RehAbilitation After Pulmonary eMBOlism: RAMBO Study (RAMBO)

Pulmonary Embolism | Quality of Life and Dyspnea

France
McMaster University

Recruiting

Impact of Pulmonary Rehabilitation on Loneliness in COPD

Loneliness

Canada
University of British Columbia

Completed

Sprint Snacks: The Effects of Prolonged Rest on Reduced Exertion Interval Training.

Cardiorespiratory Fitness

Canada
Pfizer

Completed

A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine

Overactive Bladder

Korea, Republic of, United States, Denmark, Germany, Canada, Hungary, Poland, France, United Kingdom, Slovakia, Sweden, Mexico, Czech Republic, Finland, Italy, Lithuania, Argentina, Chile, Colombia, Egypt, Greece, Norway, Philippines, Russian Federation and more
London School of Hygiene and Tropical Medicine
Wellcome Trust

Completed

Experimental Study to Assess Interventions Aimed at Improving the Equity Impact of Community-Based Health Insurance

Health Insurance

India
Aveiro University
Fundação para a Ciência e a Tecnologia

Completed

Home-monitoring and Adherence of Patients With COPD to Long-term Rehabilitation

Chronic Obstructive Pulmonary Disease (COPD)

Portugal
Pfizer

Completed

A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients

Overactive Bladder

Costa Rica, United States, Korea, Republic of, Germany, Slovakia, Ukraine, Belgium, Poland, Czechia
Pfizer

Terminated

Non-Interventional Study To Investigate Whether Information Provided To Patients Influences Their Satisfaction With Toviaz Therapy

Urinary Bladder, Overactive
Grünenthal GmbH

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GRT9906 Prolonged Release Tablets After Dose Escalation in Healthy Subjects

Pharmacokinetics

Germany
Chang Gung Memorial Hospital

Unknown

Osteoporosis in Chronic Obstructive Pulmonary Disease (COPD)

Osteoporosis | COPD,

Taiwan
University of Nebraska
National Cancer Institute (NCI); Amgen

Completed

Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

Peripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Recurrent Adult T-cell Leukemia/Lymphoma

United States
Pfizer

Completed

Study To Assess The Bioequivalence Under Fed And Fasted Conditions Of The Fesoterodine Beads-In-Capsule SR4 And SR7 Formulations And To Estimate The Bioavailability of SR7 Beads Sprinkled On Apple Sauce Relative To The Beads-In-Capsule SR7 Formulation Administer

Neurogenic Detrusor Overactivity

Belgium
Pfizer

Completed

A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder. (SOFIA)

Urinary Bladder, Overactive

Portugal, Spain, Turkey, Finland, Germany, Norway, Sweden, Slovakia, Italy, Austria, United Kingdom, Belgium, Denmark, Israel, Switzerland
Mundipharma Research GmbH & Co KG

Completed

Optimisation of Hydromorphone - Naloxone Ratio for the Treatment of Pain (HMX3501)

Constipation

Romania, Switzerland, Israel, Belgium, Germany, Australia, Austria, Czech Republic, Denmark, Finland, France, Netherlands, Poland, United Kingdom
Göteborg University

Recruiting

RCT of PR-ESSENCE - a Problem Solving Model for Youth With Challenging Behavior in Special (SiS) Treatment Homes

Neurodevelopmental Disorders | Behavior Problems

Sweden
University of Alberta
University of Calgary

Completed

Examining Pulmonary Rehabilitation on Discharged COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)

Canada
Amgen

Completed

Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function

Renal Insufficiency | Multiple Myeloma

United States
Columbia University
National Center for Complementary and Integrative Health (NCCIH)

Completed

Capnography-Assisted Learned Monitored (CALM) Breathing Therapy for COPD (CALM)

COPD

United States
Sociedad Española de Neumología y Cirugía Torácica

Completed

Cost/Effectiveness Analysis of the Respiratory Poligraphy at Home (Telesleep)

Suspected Sleep Apnea | Daytime Sleepiness

Spain
Göteborg University

Completed

PR-ESSENCE for Youth With Challenging Behavior

Behavior Problem of Childhood and Adolescence
Pfizer

Completed

Drug Use Investigation for Toviaz

Overactive Bladder (OAB)
Pfizer

Completed

Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy

Overactive Bladder | Urinary Incontinence

Slovakia
The First Affiliated Hospital of Guangzhou Medical...

Recruiting

Effectiveness of Harmonica Playing in Improving Lung Function Among COPD Patients

COPD

China
Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Lifestyle Program for Obstructive Sleep Apnea With Severe Obesity

Obesity | Obstructive Sleep Apnea

United States
University of Oklahoma

Active, not recruiting

Sacrocolpopexy With Posterior Repair Obstructed Defecation Symptoms

Vaginal Prolapse

United States
Amgen

Completed

A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols

Multiple Myeloma | Solid Tumors

United States, Canada
AdvanceCor GmbH
Procorde GmbH

Completed

Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion (PR-15/01)

Myocardial Infarction | Stroke | Thrombosis | Acute Coronary Syndrome

Germany
Pfizer

Completed

A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy Volunteers

Urinary Bladder, Overactive

Singapore
Washington University School of Medicine

Completed

Comparative Urine Proteomic Studies of Overactive Bladder in Humans

Overactive Bladder

United States
Pfizer

Completed

Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder.

Overactive Bladder

Japan
Pfizer

Completed

A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.

Urinary Bladder, Overactive

Canada, United States, Germany, Russian Federation, Czechia, Egypt, Bulgaria, Finland, Hungary, Korea, Republic of, Mexico, Poland, South Africa, Sweden, Ukraine
Mayo Clinic

Terminated

Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate

Overactive Bladder

United States
Proacta, Incorporated

Terminated

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

Lung Cancer

United States
Proacta, Incorporated
National Cancer Institute (NCI)

Completed

PR-104 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of North Carolina, Chapel Hill
National Institute on Aging (NIA)

Completed

Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE) (URGE)

Urge Urinary Incontinence

United States
Pfizer

Completed

Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.

Overactive Bladder

Korea, Republic of, Taiwan, Hong Kong, Japan
Mayo Clinic

Recruiting

Breathing Training and Exercise Capacity in Non-CFB

Non-cystic Fibrosis Bronchiectasis

United States
Marmara University

Unknown

The Effect of Body Awareness Therapy on Postural Stability, Balance and Fear of Falling in Patients With COPD

Asthma

Turkey
Aveiro University

Completed

Impact of Feedback on Physical Activity and Health-related Outcomes During Pulmonary Rehabilitation in COPD

Pulmonary Disease, Chronic Obstructive
Saint Thomas Health
Pfizer

Withdrawn

Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients

Urinary Incontinence | Bladder Dysfunction

United States

Search clinical trials for: Fesoterodine PR

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations